Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
about
Performance of the BioPlex 2200 HIV Ag-Ab assay for identifying acute HIV infection.In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study.Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study.Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care.Pre-exposure Prophylaxis as HIV Prevention in High Risk Adolescents
P2860
Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Daily and non-daily pre-exposu ...... ed, open-label, phase 2 trial.
@en
type
label
Daily and non-daily pre-exposu ...... ed, open-label, phase 2 trial.
@en
altLabel
Daily and non-daily pre-exposu ...... sed, open-label, phase 2 trial
@en
prefLabel
Daily and non-daily pre-exposu ...... ed, open-label, phase 2 trial.
@en
P2093
P2860
P50
P1433
P1476
Daily and non-daily pre-exposu ...... ed, open-label, phase 2 trial.
@en
P2093
Bonnie J Dye
Craig W Hendrix
Elaine Sebastien
HPTN 067 (ADAPT) study team
James F Rooney
James P Hughes
Laura McKinstry
Mark A Marzinke
Michael Stirratt
P2860
P304
P356
10.1016/S2352-3018(17)30156-X
P407
P577
2017-10-03T00:00:00Z